Skip to main content
Search

Research & development of new pharmaceuticals for treatment of endometriosis

Published on April 30, 2019   49 min

A selection of talks on Pharmaceutical Sciences

Please wait while the transcript is being prepared...
0:00
Hi everybody. Thank you for your interest to my talk. My name is Wang Chi Chiu Ronald, or you can call me Ronald. I am the Professor and Division Head of the Department of O&G in The Chinese University of Hong Kong. Here's where we all know, I'm happy to have a talk in Henry Stewart Talks. The topic of my talk is "R&D of New Pharmaceuticals for Treatment of Endometriosis". From the topic, you can see that I'm going to cover the treatment of endometriosis and R&D of the new pharmaceuticals. So, I hope you like it and find it very useful.
0:41
So, first of all, I would like to disclose my collaborations, funding, patents, and licenses. So, you can see that I have several collaborations with Hiu Xu in Hong Kong, McGill University and University of Oxford and also Havard University, Columbia University, and South Carolina. The funding mainly is from Hong Kong. One of them is RGC GRF, the second is ITF Tier 3 ITS and the last one is the HMRF. So, some of the contacts have a patents already. So, you can identify the ID of the patents here. One of the technology has been licensing through the pharmaceutical company.
1:29
So, basically, the talk today will cover three areas. First of all, I will give you some background information, such as why we need the pharmaceuticals and how we are going to design the new pharmaceuticals. So we're going to talk about some physiology. In the second part, we are going to introduce four main new pharmaceuticals that includes progesterone, immunodulators, herbal medicine, and lastly I'm going to give you a summary.

Quiz available with full talk access. Request Free Trial or Login.

Show
Hide

Research & development of new pharmaceuticals for treatment of endometriosis

Embed in course/own notes